Formulation and method for the prevention and/or treatment of hangover symptoms

a technology for hangover and formulation, applied in the direction of heterocyclic compound active ingredients, drug compositions, dispersed delivery, etc., can solve the problems of high productivity loss, loss of hours of work and relaxation time, and inability to effectively metabolize all the acetaldehyde produced, etc., to achieve convenient dispensing of products, convenient separation of two sachets, and relative ease of separation

Inactive Publication Date: 2019-04-11
PHOENIX PHARMA AUSTRALIA PTY LTD
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0055]For example, the tear difficulty can alternate such that it is, for example, relatively easier to separate two sachets at a time from a length of sachets (than it would be to separate each sachet from a pair). Such embodiments facilitate dispensing of the product in pairs of sachets. Some of these embodiments are provided in the form of a reel, wherein the desirable number of sachets to be acquired can be dispensed by tearing the tearable join when the reel has been unwound sufficiently to expose the desired number of sachets.
[0056]The join between sachet

Problems solved by technology

However, when too much alcohol is consumed the body is overwhelmed and cannot effectively metabolize all the acetaldehyde that is being produced.
Alcohol induced hangover is responsible for a significant degree of morbidity in the community and it is responsible for a high level of loss of productivity due to absenteeism from work and poor work performance [10, 12, 15].
Due to side effects such as headache, nausea and a general feeling of malaise many hours of work and relaxation time are lost because of the inability to be productive.
However, PubMed database searches of the ingredients variously contained in those products reveal that none of them have been studied, other than Red Ginseng and glucose [6, 19].
Specifically, disulfiram is prescribe

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Formulation and method for the prevention and/or treatment of hangover symptoms
  • Formulation and method for the prevention and/or treatment of hangover symptoms
  • Formulation and method for the prevention and/or treatment of hangover symptoms

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0077]According to particularly preferred embodiments, the inventors have developed a novel formulation which, for the purpose of trials undertaken described in the Example given below, has been named. CJ1484.

[0078]CJ1484 is a formulation comprised of vitamins and amino acids. The ingredients are non-toxic dietary compounds that are essentially free from side effects. In one of the preferred embodiments of the invention, which was used in this study, the formulation is in a powder form. All active ingredients are readily absorbed through the gastrointestinal tract.

[0079]CJ1484 comprises the following active ingredients:

[0080](1) L-Cysteine

[0081]L-cysteine is an amino acid, one of the building blocks for proteins in humans. It was discovered in 1810 and found to be essential to the diet of humans. L-cysteine is produced in the body by the conversion from serine and methionine. It plays a crucial role in reversing oxidization in the liver partially due to conversion to glutathione. L-...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to view more

Abstract

A formulation and a method for treating, preventing, ameliorating or alleviating in a patient the symptoms of hangover, or of veisalgia, associated with a bout of excessive alcohol consumption are disclosed. More specifically, a formulation comprising L-cysteine, thiamine and pyridoxine and a method for treating, preventing, ameliorating or alleviating in a patient one or more of the symptoms of nausea, headache, diminished concentration, malaise and/or tiredness, and a desire to consume greasy and/or fatty and/or oily foods, associated with a bout of excessive alcohol consumption are disclosed.

Description

FIELD OF THE INVENTION[0001]The invention relates to formulations and methods for the prevention and / or treatment of hangover symptoms associated with alcohol consumption.BACKGROUND TO THE INVENTION[0002]Alcohol induced hangover, also known as veisalgia, is a syndrome comprised of a range of symptoms including nausea, headache, diminished concentration, malaise and / or tiredness, and a desire to consume greasy and / or fatty and / or oily foods (amongst others) that typically occurs the day following overindulgence in alcohol. Although the precise pathogenesis of hangover is not known and likely to be due to multiple factors, there is considerable evidence that the accumulation of acetaldehyde plays a significant role [14, 15, 16, 17]. Alcohol is rapidly metabolized to acetaldehyde by the enzyme alcohol dehydrogenase. Acetaldehyde is then metabolized by aldehyde reductase to acetate.[0003]The following formulas illustrate these reactions:CH3CH2OH+NAD+→CH3CHO+NADH+H+  1)Acetaldehyde+NAD++...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/198A61K31/51A61K31/4415A61K31/375A61K31/7004A61P25/32
CPCA61K31/198A61K31/51A61K31/4415A61K31/375A61K31/7004A61P25/32A61K9/009A61K9/0095A61K9/145A61K2300/00
Inventor HOWES, LAURENCE GUYQUINTON, JAN BEATRICE
Owner PHOENIX PHARMA AUSTRALIA PTY LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products